Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept Combined with Methotrexate in Severe Plaque Psoriasis
NCT02313922Phase 4Completed
- Sponsor
- Zhejiang University
- Start
- Nov 2014
- Primary completion
- Aug 2018
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etanercept in plaque psoriasis (2 arms), sponsored by Zhejiang University. Primary endpoint: Psoriasis Area and Severity Index 75 at 24 weeks. Started Nov 2014; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02313922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02313922.